PIRAMAL ENTERPRISES LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1058.7
- Today's High:
- ₹1134.65
- Open Price:
- ₹1131
- 52W Low:
- ₹630.2
- 52W High:
- ₹2084.45
- Prev. Close:
- ₹1127.1
- Volume:
- 70418
Company Statistics
- Market Cap.:
- ₹169.27 billion
- Book Value:
- 1355.494
- Revenue TTM:
- ₹131.53 billion
- Operating Margin TTM:
- 60.08%
- Gross Profit TTM:
- ₹115.47 billion
- Profit Margin:
- 0.54%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
PIRAMAL ENTERPRISES LTD. had its IPO on under the ticker symbol PEL.
The company operates in the Financials sector and Banking Services industry. PIRAMAL ENTERPRISES LTD. has a staff strength of 6,579 employees.
Stock update
Shares of PIRAMAL ENTERPRISES LTD. opened at ₹1131 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1058.7 - ₹1134.65, and closed at ₹1063.5.
This is a -5.64% slip from the previous day's closing price.
A total volume of 70,418 shares were traded at the close of the day’s session.
In the last one week, shares of PIRAMAL ENTERPRISES LTD. have slipped by -1.99%.
PIRAMAL ENTERPRISES LTD.'s Key Ratios
PIRAMAL ENTERPRISES LTD. has a market cap of ₹169.27 billion, indicating a price to book ratio of 0.7353 and a price to sales ratio of 1.3799.
In the last 12-months PIRAMAL ENTERPRISES LTD.’s revenue was ₹131.53 billion with a gross profit of ₹115.47 billion and an EBITDA of ₹83.85 billion. The EBITDA ratio measures PIRAMAL ENTERPRISES LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, PIRAMAL ENTERPRISES LTD.’s operating margin was 60.08% while its return on assets stood at 0% with a return of equity of 0%.
In Q1, PIRAMAL ENTERPRISES LTD.’s quarterly earnings growth was a negative -8.4% while revenue growth was a negative 16%.
PIRAMAL ENTERPRISES LTD.’s PE and PEG Ratio
- Forward PE
- 149.2537
- Trailing PE
- 233.0745
- PEG
Its diluted EPS in the last 12-months stands at ₹3.22 per share while it has a forward price to earnings multiple of 149.2537 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PIRAMAL ENTERPRISES LTD.’s profitability.
PIRAMAL ENTERPRISES LTD. stock is trading at a EV to sales ratio of 2.6614 and a EV to EBITDA ratio of 3.1526. Its price to sales ratio in the trailing 12-months stood at 1.3799.
PIRAMAL ENTERPRISES LTD. stock pays annual dividends of ₹14 per share, indicating a yield of 1.9% and a payout ratio of 18.36%.
Balance sheet and cash flow metrics
- Total Assets
- ₹46,768.21 billion
- Total Liabilities
- ₹11.92 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 18.36%
PIRAMAL ENTERPRISES LTD. ended 2024 with ₹46,768.21 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹46,768.21 billion while shareholder equity stood at ₹310.59 billion.
PIRAMAL ENTERPRISES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹11.92 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹2.72 billion in goodwill. Its cash balance stood at ₹37.29 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹495.11 billion.
PIRAMAL ENTERPRISES LTD.’s total current assets stands at ₹46,479.74 billion while long-term investments were ₹0 and short-term investments were ₹9.20 billion. Its net receivables were ₹194.00 million compared to accounts payable of ₹3.99 billion and inventory worth ₹0.00.
In 2024, PIRAMAL ENTERPRISES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, PIRAMAL ENTERPRISES LTD. paid ₹0.18 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1063.5
- 52-Week High
- ₹2084.45
- 52-Week Low
- ₹630.2
- Analyst Target Price
- ₹
PIRAMAL ENTERPRISES LTD. stock is currently trading at ₹1063.5 per share. It touched a 52-week high of ₹2084.45 and a 52-week low of ₹2084.45. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1024.29 and 200-day moving average was ₹830.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4939.5% of the company’s stock are held by insiders while 2881.1% are held by institutions.
Frequently Asked Questions About PIRAMAL ENTERPRISES LTD.
Similar Industry Stocks (Banking Services)
Most Active
Top Gainers
Top Losers
About
Piramal Enterprises Limited produces and sells pharmaceutical, medicinal, and chemical and botanical products in India and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company offers contract development and manufacturing solutions across the drug life cycle, including drug discovery, clinical development, and commercial manufacturing of active pharmaceutical ingredients (API) and formulations. It also provides inhalation anaesthetics, including Sevoflurane, Isoflurane, and Halothane; Intrathecal Baclofen therapy for spasticity management; injectable anaesthesia/pain management products; and API generics, vitamins and nutritions, and premixes. In addition, the company offers over-the-counter products for skin care, pain management, oral care, respiratory, gastro-intestinal, women’s health, and baby care and kids wellbeing primarily under the Saridon, Lacto Calamine, I-Pill, Supradyn, Polycrol, and Tetmosol brands. Further, it provides PhytoMedicines products to manage lifestyle ailments, such as cough-cold, women-care range, stress relievers, sleep disorders, piles, skin care-topicals, immunity enhancer, liver disorder, and others. Additionally, the company offers a suite of financial products to various real estate developers and under special situation opportunities in various sectors; and engages in investment activities. Piramal Enterprises Limited has strategic alliances with APG Asset Management, Bain Capital Credit, CPPIB Credit Investment Inc., and Ivanhoé Cambridge. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India.